FindTrial
Sign In

The real world of effects of COVID-19 on patients with hemophilic arthritis in mainland China

The real world of effects of COVID-19 on patients with hemophilic arthritis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300068885
Enrollment
Unknown
Registered
2023-03-01
Start date
2023-03-01
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemophiliac arthritis

Interventions

Case series:N/A

Sponsors

The First Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Age >= 18 years (2) Diagnosed with type A or B hemophilia, (3) Evidence of MRI-confirmed synovial, cartilage or bony lesions, (4) Able to understand and agree with the informed consent.

Exclusion criteria

Exclusion criteria: Patients with vascular hemophilia, acquired hemophilia and/or congenital hemorrhagic diseases other than HA and HB

Design outcomes

Primary

MeasureTime frame
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score;visual analogue scale,VAS;Hemophilia combined health score, HJHS;SF-36;—

Countries

China

Contacts

Public ContactGuo Jiongjiong

The First Affiliated Hospital of Soochow University

drjjguo@163.com+86 180 1356 3327

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026